Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 697, doi. 10.1038/mt.2008.286
- By:
- Publication type:
- Article
Works matching IS 15250016 AND DT 2009 AND VI 17 AND IP 4
Results: 23
1
2
Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 685, doi. 10.1038/mt.2008.297
- By:
- Publication type:
- Article
3
Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 725, doi. 10.1038/mt.2008.298
- By:
- Publication type:
- Article
4
Tolerance Induction Using Lentiviral Gene Delivery Delays Onset and Severity of Collagen II Arthritis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 632, doi. 10.1038/mt.2009.299
- By:
- Publication type:
- Article
5
Adoptive Immunotherapy of Disseminated Leukemia With TCR-transduced, CD8<sup>+</sup> T Cells Expressing a Known Endogenous TCR.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 742, doi. 10.1038/mt.2008.300
- By:
- Publication type:
- Article
6
Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 593, doi. 10.1038/mt.2008.301
- By:
- Publication type:
- Article
7
Enzyme Replacement Improves Ataxic Gait and Central Nervous System Histopathology in a Mouse Model of Metachromatic Leukodystrophy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 600, doi. 10.1038/mt.2008.305
- By:
- Publication type:
- Article
8
ICP0 Inhibits the Decrease of HSV Amplicon-mediated Transgene Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 707, doi. 10.1038/mt.2008.306
- By:
- Publication type:
- Article
9
Redundant and Synergistic Mechanisms Control the Sequestration of Blood-born Adenovirus in the Liver.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 675, doi. 10.1038/mt.2008.307
- By:
- Publication type:
- Article
10
Intradermal Delivery of Plasmid VEGF<sub>165</sub> by Electroporation Promotes Wound Healing.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 651, doi. 10.1038/mt.2009.12
- By:
- Publication type:
- Article
11
Development of a Hybrid Baculoviral Vector for Sustained Transgene Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 658, doi. 10.1038/mt.2009.13
- By:
- Publication type:
- Article
12
Optimized Lentiviral Vector Design Improves Titer and Transgene Expression of Vectors Containing the Chicken β-Globin Locus HS4 Insulator Element.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 667, doi. 10.1038/mt.2009.1
- By:
- Publication type:
- Article
13
Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 641, doi. 10.1038/mt.2009.2
- By:
- Publication type:
- Article
14
Mimicking Aspects of Frontotemporal Lobar Degeneration and Lou Gehrig's Disease in Rats via TDP-43 Overexpression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 607, doi. 10.1038/mt.2009.3
- By:
- Publication type:
- Article
15
Selective Cancer Targeting via Aberrant Behavior of Cancer Cell-associated Glucocorticoid Receptor.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 623, doi. 10.1038/mt.2009.4
- By:
- Publication type:
- Article
16
In This Issue.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 580, doi. 10.1038/mt.2009.50
- Publication type:
- Article
17
Research Highlights.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 581, doi. 10.1038/mt.2009.54
- Publication type:
- Article
18
The National Gene Vector Biorepository’s Pharm/Tox Database.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 582, doi. 10.1038/mt.2009.55
- By:
- Publication type:
- Article
19
Progress in Genetic Therapy for Severe Combined Immunodeficiency Associated With Adenosine Deaminase Deficiency.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 577, doi. 10.1038/mt.2009.57
- By:
- Publication type:
- Article
20
Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 585, doi. 10.1038/mt.2009.5
- By:
- Publication type:
- Article
21
Does the Human Skeletal Muscle Harbor the Murine Equivalents of Cardiac Precursor Cells?
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 733, doi. 10.1038/mt.2009.6
- By:
- Publication type:
- Article
22
Genomic and Functional Assays Demonstrate Reduced Gammaretroviral Vector Genotoxicity Associated With Use of the cHS4 Chromatin Insulator.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 716, doi. 10.1038/mt.2009.7
- By:
- Publication type:
- Article
23
Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 614, doi. 10.1038/mt.2009.9
- By:
- Publication type:
- Article